- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/454 - Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
Patent holdings for IPC class A61K 31/454
Total number of patents in this class: 6506
10-year publication summary
|
445
|
453
|
467
|
504
|
540
|
515
|
457
|
483
|
564
|
453
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Celgene Corporation | 1409 |
143 |
| Novartis AG | 10175 |
93 |
| Bristol-myers Squibb Company | 4764 |
75 |
| Dana-Farber Cancer Institute, Inc. | 2669 |
73 |
| Takeda Pharmaceutical Company Limited | 2699 |
71 |
| Janssen Pharmaceutica N.V. | 3160 |
70 |
| The Regents of the University of California | 20842 |
58 |
| Merck Sharp & Dohme LLC | 3738 |
51 |
| Vanda Pharmaceuticals, Inc. | 391 |
50 |
| The Children's Hospital of Philadelphia | 867 |
48 |
| Pfizer Inc. | 3413 |
44 |
| Immunomedics, Inc. | 238 |
44 |
| Abbvie Inc. | 1799 |
42 |
| Boehringer Ingelheim International GmbH | 4485 |
40 |
| Toray Industries, Inc. | 7143 |
40 |
| Mitsubishi Tanabe Pharma Corporation | 398 |
37 |
| Minerva Neurosciences, Inc. | 61 |
36 |
| F. Hoffmann-La Roche AG | 7800 |
34 |
| Tesaro, Inc. | 107 |
34 |
| Taisho Pharmaceutical Co., Ltd. | 847 |
33 |
| Other owners | 5390 |